Literature DB >> 19140279

Nevus Spitz--everlasting diagnostic difficulties--the review.

Mirna Situm1, Zeljana Bolanca, Marija Buljan, Davor Tomas, Marijana Ivancić.   

Abstract

In 1910, Darier and Civatte described in details an unusual melanocytic tumor characterized by rapid growth on the nose of a young child. They could not state whether the tumor was benign or malignant. In 1947, Sophie Spitz described the same lesion as juvenile melanoma in which prognosis was frequently excellent. Later, the study was revised and it was concluded that juvenile melanoma was a benign tumor and can affect adults. Although, the prognosis was mostly excellent, Spitz reported in one of 13 cases fatal metastases from nevus Spitz. In 1999, Barnhill et al described one fatal case of the patient for whom it was thought to have typical Spitz nevus. Nowadays, there is still a lack of consensus about histopathology and also a terminology of the tumors that are neither typical nevus Spitz, neither malignant melanoma. All histopathological, clinical and ancillary criteria must be weighed in the final interpretation of epitheloid/spindle cell lesion. At the present, the final diagnosis remains pathohistological, with important emphasis given to clinical impression. Persistently changing lesion indicates malignancy potential of the lesion. Barnhill recommends that all Spitz tumors are completely excised. Atypical tumors should be excised with wider margins up to 1 cm. Patient should be carefully monitored by regular examinations for recurrence and metastasis.

Entities:  

Mesh:

Year:  2008        PMID: 19140279

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  2 in total

1.  The diagnosis and management of the Spitz nevus in the pediatric population: a systematic review and meta-analysis protocol.

Authors:  Jean Abboud; Michael Stein; Michele Ramien; Claudia Malic
Journal:  Syst Rev       Date:  2017-04-13

2.  Spitz nevi and other Spitzoid lesions part I. Background and diagnoses.

Authors:  Su Luo; Alireza Sepehr; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2011-12       Impact factor: 11.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.